Business Wire

DEENOVA

Share
Deenova Celebrates a Year of Undisputed Growth With the Latest Award of Piacenza AUSL Public Tender

After successful market entries in Germany, UK and the 3 years of record breaking sales in France, Deenova consolidates its leadership position in Italy with the award of the Piacenza AUSL Public Tender, confirming Deenova’s 100% customer retention rate since 2007 and an undisputed technological leadership in the field of hospital pharmacy automation aimed at improving processes, patient safety and personnel time efficiency, for healthcare institutions.

The public tender named 'telematic restricted procedure for the entrusting of logistics support services and needed medical devices’ includes the Deenova flagship solutions such as Orbit software, D1 All-In-1 Stations, D1 All-In-1 Trolley, but also the All-in-1 cabinets for the handling of not unit dose medications (All-In-1 Meds, All-In-1 Fridge and All-In-1 Narcotics) and D8 RFID technology for medical devices.

"The 6 years tender at Piacenza AUSLGiorgio Pavesi, CEO of Deenova, stated - confirms the complete satisfaction with our automation solutions among the existing customer base. We provide the highest level of safety and efficiency for traceability of medications and medical devices through restless technological development: in Piacenza hospitals we’ll add new solutions to those already used such as Kanban methodology for automatic reordering of low-cost devices and Real Time Location System for traceability of the patient’s path in surgery unit”.

The Piacenza AUSL has around 750 beds in the 4 hospitals of Bobbio, Castel San Giovanni, Fiorenzuola and Piacenza, with 91 operating units, including the Mental Health Centres and the Hospital Pharmacy. During the last X SIFACT Congress "Clinical outcomes: a shared commitment and responsibility" Piacenza AUSL has been awarded as best abstract for the poster "Management of batch in single-dose therapy prepared by Hospital Pharmacy Service for Mental Health Centres". The project introduced Deenova error-free solutions to ensure the complete traceability of unit-dose therapies, favouring therapeutic adherence and clinical risk management. This medication management model can be extended to large-area warehouses for total supply chain traceability.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

Please visit www.deenova.com for additional information on its market leading solutions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221219005564/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Hosts Inclusion International 18th World Congress 2025 ‘We Are Inclusion’ for the First Time, With 600 Participants From 74 Countries19.9.2025 19:07:00 CEST | Press release

Sharjah hosted the 18th edition of the World Congress 2025 “We Are Inclusion” for the first time in the Middle East and North Africa, under the patronage and in the presence of His Highness Sheikh Dr. Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919788186/en/ Honorary Lifetime Membership certificate awarded to Sheikha Jameela bint Mohammed Al Qasimi by Inclusion International (Photo: AETOSWire) The event was held from September 15 - 17 at Expo Centre Sharjah, and organised by the Sharjah City for Humanitarian Services (SCHS) and Inclusion International, with support from the strategic partnership of the Sharjah Government Media Bureau. The congress brought together 152 speakers, including self-advocates, families, experts, and policymakers from 160 organisations across 74 countries, featuring 59 sessions, with 600 participants. During the event,

Estithmar Holding’s Listing on FTSE Mid Cap Index is Effective19.9.2025 17:02:00 CEST | Press release

As of September 18, The Qatar based Estithmar Holding Q.P.S.C. has been included in the FTSE Mid Cap Index following the September 2025 FTSE Global Equity Index Series (GEIS) Semi-Annual Review. Changes will be effective as of COB 18 Sep 2025.This inclusion reflects Estithmar Holding’s growing footprint in both regional and global markets, further strengthening its visibility among international investors and underlining its position as one of the region’s leading diversified public companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919701856/en/ Estithmar Holding’s Listing on FTSE Mid Cap Index is Effective (Photo: AETOSWire) The FTSE Russell index is widely tracked by international institutional investors and asset managers, and Estithmar Holding’s inclusion is expected to broaden its investor base globally, resulting in significant investment flows. The move also contributes to improving the financial attractive

LambdaTest Leads with First-to-Market Support for iPhone 17 Series on Real Devices19.9.2025 17:00:00 CEST | Press release

With iPhone 17 Series Testing Now Live, LambdaTest Boosts Developer Productivity and Streamlines Mobile App Testing Processes LambdaTest, the GenAI-native quality engineering platform, has announced the immediate availability of the iPhone 17 Series, including the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and the iPhone Air, on its Real Devices Platform, just hours after the official launch of Apple’s latest lineup. The addition of the iPhone 17 series further enhances LambdaTest’s already robust real device cloud, which spans thousands of iOS and Android devices. This expansion enables comprehensive cross-device and cross-OS testing at scale, ensuring developers can thoroughly test their mobile apps across a diverse range of real-world environments. “Once again, we’re the first to offer the latest iPhone models for real device testing,” said Asad Khan, CEO and Co-Founder of LambdaTest. “This launch is a testament to our commitment to providing the most up-to-date testing solutions

World-renowned Blood Transfusion Congress to Be Held in Yokohama in 202819.9.2025 17:00:00 CEST | Press release

The 2028 International Congress of the International Society of Blood Transfusion (ISBT 2028) will be held in Yokohama from June 4 to June 8, 2028. Organized collaboratively by ISBT and The Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), this marks the event’s return to Japan after 19 years, following three previous international (1960, 1996) and regional congresses (2009) held in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919907189/en/ YOKOHAMA JAPAN'S FIRST PORT OF CALL Working in partnership with the City of Yokohama and the Japan National Tourism Organization (JNTO), the Yokohama City Visitors Bureau (YCVB) and PACIFICO Yokohama supported JSTMCT’s successful bid to host ISBT 2028. The decision is testament to Japan’s advanced research capabilities, Yokohama’s convenient access and robust support infrastructure, and PACIFICO Yokohama’s outstanding reputation for hosting international c

OCP Announces Date of Second Quarter and First Half 2025 Earnings19.9.2025 14:30:00 CEST | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2025 results on Friday, September 26, 2025. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 11:00 a.m. EDT, 4:00 p.m. Morocco and London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2025 results at 12:00 p.m. EDT, 5:00 p.m. Morocco and London time (GMT+1) on Friday, September 26, 2025, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century’s production history. OCP has exc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye